Eoghan de Barra received his medical degree from the Royal College of Surgeons in Ireland, Dublin and proceeded to gain specialist training in Infectious Diseases and General Medicine in Ireland and South Africa.
In 2011 he took up a post as Research Fellow and Lecturer in the department of Tropical Medicine and International Health at the RCSI and conducted malaria vaccine research work in Dublin and at the University of Oxford, UK.
In 2014 he went to Imperial College NHS Trust, London as a Consultant in Infectious Diseases and General Internal Medicine, where he was the clinical lead for the OPAT programme, a site lead for Neuro-Infection, a regional lead for TB including large numbers of MDR TB and led the Trust’s Ebola response, as well as directing and advising Infection Prevention and Control practitioners as part of an integrated Clinical Infection unit. He served as a supervisor for joint Microbiology, Virology, Infectious Diseases and General Medicine trainees on RCPath and JRCPTB schemes, and for Advanced Nurse Practitioner and Pharmacist independent prescribing candidates.
In 2017 he returned to Dublin taking up a post as Consultant in Infectious Diseases and Senior Lecturer at Beaumont Hospital / RCSI. Research interests include Tropical Medicine, vaccine development, TB, resource limited acute care, OPAT and antimicrobial prescribing.
Professor Karina Butler is UCD Clinical Professor of Paediatrics, Consultant Paediatrician and Infectious Diseases Specialist at Children’s Health Ireland at Crumlin and Temple Street Children's University Hospital. A former president of the Infectious Diseases Society of Ireland (2018-2020), she chairs the National Immunisation Advisory Committee of the Royal College of Physicians of Ireland and is Chair of PENTA Foundation UK, an independent charity that seeks to promote research into infectious disease in children as part of the wider Penta Network. Appointed to the National Public Health Emergency Team in late 2020, she is also a member of the COVID-19 Expert Advisory Group of the Health Information and Quality Authority. She has served on the national tuberculosis and scientific advisory committees of the Health Protection Surveillance Centre, the steering committee member of the Paediatric European Network for Treatment of AIDS and Infectious Diseases (PENTA-ID). Her clinical research has focussed on prevention and management of HIV infection in children and adolescents. As Chair of the National Immunisation Advisory Committee she is committed to the prevention of infectious diseases using safe and effective vaccines, thus protecting the health of our population.
Dr. Eoin Feeney graduated in medicine from Trinity College Dublin in 2002. He completed his basic specialist training through the Mater Misericordiae University Hospital training scheme, spending six months as a resident at the Mayo Clinic in Rochester, Minnesota. In 2012 he completed Higher Specialist Training in Infectious Diseases and General Internal Medicine through the Royal College of Physicians in Ireland, and in the same year was awarded a PhD examining the metabolic complications of HIV infection from University College Dublin. From 2012-2014 he undertook a Fellowship in Infectious Diseases at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. From 2013-2014 he was an Instructor in Medicine at Harvard Medical School. He was awarded the Massachusetts Infectious Diseases Society Edward H. Kass Award for Clinical Excellence in 2014. His areas of research at MGH/BWH were the mechanisms of accelerated fibrosis in HIV / hepatitis C virus co-infection. In 2014 he returned to Ireland as a Consultant Physician in Infectious Diseases and established the Infectious Diseases department at St. Vincent’s University Hospital and St. Vincent’s Private Hospital.
Dr. Catherine Fleming, National Speciality Director of Infectious Diseases, Royal College of Physicians of Ireland Dr Catherine Fleming graduated from University College Dublin in 1990. She trained in Infectious Diseases at Boston Medical Centre, Boston, Massachusetts, and received a Masters in Public Health from Harvard University. She was appointed Assistant Professor at Boston University in 2000. Dr Fleming took up her appointment as Consultant in Infectious Disease in Galway University Hospital in 2004 and she is the lead Infectious Disease physician for the Saolta Hospital group. She is the National Specialty Director of Infectious Diseases in Ireland. In addition to other responsibilities she is currently a Member of the Steering Group for a National Sexual Health Strategy and is a member of the National Training Body Committee.
Professor Mary Horgan is President of the Royal College of Physicians of Ireland, former Dean of the School of Medicine at UCC and Consultant Physician in Infectious Diseases at Cork University Hospital. She graduated from University College Dublin in 1986.
Professor Horgan undertook a Fellowship in Infectious Diseases in Washington University Medical School, St Louis, USA and was appointed Assistant Professor of Medicine in 1995. She returned to Ireland in 1997 to take up the position of Consultant in Infectious Diseases.
Professor Horgan was appointed as Dean of the Medical School in UCC in 2013 and held the position for a 4-year term.
Professor Horgan has been a Ministerial appointment of number of Health service-related National Boards including HPRA and IBTS. She was appointed Chair of the National Research Ethics Committee on COVID-19, is a member of the COVID-19 Rapid Testing Group reporting to the Minister for Health and a member of the group reporting on the strategy for Whole Genomic Sequencing of Variants. She is on the GAA’s expert Advisory Committee on COVID19 and worked with World Rugby on Return to Play strategy. She has worked on the frontline at Cork University Hospital during each wave of the pandemic.
She was awarded the UCD Alumni award for health in 2019.
Professor Horgan was elected as President of the Royal College of Physicians of Ireland, the first women to hold this position since the College’s foundation in 1654.